Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Prednicarbate→

Prednicarbate Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
73771-04-7
Molecular formula
C27H36O8
Molecular weight
488.6 g/mol
Drug class
Topical non-halogenated glucocorticoidcorticosteroid receptor agonist
Mechanism of action
Activates glucocorticoid receptors in skin and suppresses inflammatory cytokines, leukocyte migration and immune responses, reducing erythema, oedema and pruritus.
Indications / reported uses
  • Short-term topical treatment of corticosteroid-responsive inflammatory dermatoses, including atopic dermatitis and eczema; use potency, application area and duration according to product label

Sources: US DailyMed — Prednicarbate topical emulsion/ointment · NLM MeSH — Prednicarbate · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Prednicarbate Environmental Risk Assessment (ERA) (the Prednicarbate ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.